Differences in Lexapro dosage for each condition While Lexapro treats both conditions, the dosage approach can differ slightly
Customs data reveals that imports of peptides from China have nearly doubled in one year
PREVIEW Wells Fargo & Company Q1 2022 Earnings Conference Call April 14, 2022 Executives in Attendance: John Campbell - Director, IR Charlie Scharf - CEO Mike Santomassimo - CFO Analysts Present: Scott Siefers - Piper Sandler Steven Chubak - Wolfe Research John Pancari - Evercore ISI Ken Usdin - Jefferies John McDonald - Autonomous Research Ebrahim Poonawala - Bank of America Betsy Graseck - Morgan Stanley Matt OConnor - Deutsche Bank Erika Najarian - UBS Charles Peabody - Portales Partner Gerard Cassidy - RBC Capital Market Erika Najarian - UBS Comments from Charlie Scharf - CEO: Now, let me update you on progress weve made on our strategic priorities
Additionally, 26.5% of participants receiving orlistat achieved at least a 5% reduction in BMI, compared to 15.7% in the placebo group
Dizziness or lightheadedness Uncommon, and when reported, usually mild and short-lived
Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy
